EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biomarkers for cancer therapy-related cardiovascular toxicity

Jiaxin Song, Shuqin Liu, Xiaohui Shi, Junli Gao, Michail Spanos, Qiulian Zhou, Junjie Xiao

International Review of Cell and Molecular Biology · 2026

DOI: 10.1016/bs.ircmb.2024.12.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Review of Cell and Molecular Biology, 2026. Verfasst von Jiaxin Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) and School…. Hauptthemen laut MEDLINE: Neoplasms, Biomarkers, Antineoplastic Agents, Cardiotoxicity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 181 Literaturangaben. Gefördert von: Shanghai Municipal Education Commission, National Natural Science Foundation of China, Shanghai Lingjun Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer treatment-induced cardiovascular toxicity (CTR-CVT) represents a significant challenge, with molecular mechanisms involving oxidative stress, inflammation, and direct cardiomyocyte damage. Common treatments such as anthracyclines and targeted therapies like trastuzumab are known to disrupt cardiac function through mechanisms including mitochondrial dysfunction, dysregulation of ion channels, and induction of apoptosis. Traditional biomarkers for CTR-CVT have included cardiac troponins and natriuretic peptides, which reflect acute myocardial injury and heart failure. Recent advances have introduced novel biomarkers such as microRNAs (miRNAs), including miR-29 and miR-223-3p, and proteomic markers like immunoglobulins and cytokines, which offer insights into subclinical cardiac damage and inflammatory responses. High-throughput technologies, including aptamers and proximity extension assays, have further enhanced the ability to screen for biomarkers with increased specificity and sensitivity. Integrating these traditional and emerging biomarkers provides a comprehensive approach for early detection of CTR-CVT, ultimately helping improve patient outcomes in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsBiomarkersAntineoplastic AgentsCardiotoxicityCardiovascular DiseasesHumansAnimalsMicroRNAs

Stichwörter der Autor:innen

BiomarkerCancer therapyCardiovascular toxicity

Substanzen

BiomarkersAntineoplastic AgentsMicroRNAs

Autor:innen und Institutionen

  • Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) and School of Life Science, Shanghai University, Nantong, P.R. China; Institute…
  • Cardiovascular Division of the Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States; Albert Einstein College of Medicine/NCB/Jacobi Medical Center, Bronx, NY, United States.

Förderung

  • Shanghai Municipal Education Commission
  • National Natural Science Foundation of China
  • Shanghai Lingjun Program
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Song, J., Liu, S., Shi, X., Gao, J., Spanos, M., Zhou, Q., & Xiao, J. (2026). Biomarkers for cancer therapy-related cardiovascular toxicity. International Review of Cell and Molecular Biology. https://doi.org/10.1016/bs.ircmb.2024.12.003

Vancouver

Song J, Liu S, Shi X, Gao J, Spanos M, Zhou Q, et al. Biomarkers for cancer therapy-related cardiovascular toxicity. International Review of Cell and Molecular Biology. 2026. doi:10.1016/bs.ircmb.2024.12.003

BibTeX
@article{Song2026,
  author = {Song, Jiaxin and Liu, Shuqin and Shi, Xiaohui and Gao, Junli and Spanos, Michail and Zhou, Qiulian and Xiao, Junjie},
  title = {Biomarkers for cancer therapy-related cardiovascular toxicity},
  journal = {International Review of Cell and Molecular Biology},
  year = {2026},
  doi = {10.1016/bs.ircmb.2024.12.003}
}
Kostenlos starten →